David Steel1. 1. Sunderland Eye Infirmary, Sunderland, UK.
Abstract
INTRODUCTION: Rhegmatogenous retinal detachment (RRD) is the most common form of retinal detachment, where a retinal 'break' allows the ingress of fluid from the vitreous cavity to the subretinal space, resulting in retinal separation. It occurs in about 1 in 10,000 people a year. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of different surgical interventions in people with rhegmatogenous retinal detachment? What are the effects of interventions to treat proliferative vitreoretinopathy occurring as a complication of retinal detachment or previous treatment for retinal detachment? We searched: Medline, Embase, The Cochrane Library, and other important databases up to September 2013 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). RESULTS: We found 14 studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions. CONCLUSIONS: In this systematic review, we present information relating to the effectiveness and safety of the following interventions: corticosteroids, daunorubicin, fluorouracil plus low molecular weight heparin, pneumatic retinopexy, scleral buckling, short-acting or long-acting gas tamponade, silicone oil tamponade, and vitrectomy.
INTRODUCTION:Rhegmatogenous retinal detachment (RRD) is the most common form of retinal detachment, where a retinal 'break' allows the ingress of fluid from the vitreous cavity to the subretinal space, resulting in retinal separation. It occurs in about 1 in 10,000 people a year. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of different surgical interventions in people with rhegmatogenous retinal detachment? What are the effects of interventions to treat proliferative vitreoretinopathy occurring as a complication of retinal detachment or previous treatment for retinal detachment? We searched: Medline, Embase, The Cochrane Library, and other important databases up to September 2013 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). RESULTS: We found 14 studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions. CONCLUSIONS: In this systematic review, we present information relating to the effectiveness and safety of the following interventions: corticosteroids, daunorubicin, fluorouracil plus low molecular weight heparin, pneumatic retinopexy, scleral buckling, short-acting or long-acting gas tamponade, silicone oil tamponade, and vitrectomy.
Authors: David G Charteris; G William Aylward; David Wong; Carl Groenewald; Riaz H Y Asaria; Catey Bunce Journal: Ophthalmology Date: 2004-12 Impact factor: 12.079
Authors: M S Cox; S P Azen; C C Barr; K L Linton; K R Diddie; M Y Lai; H M Freeman; A Irvine Journal: Ophthalmology Date: 1995-12 Impact factor: 12.079
Authors: Vincenza Bonfiglio; Mario D Toro; Antonio Longo; Teresio Avitabile; Robert Rejdak; Katarzyna Nowomiejska; Tomasz Choragiewicz; Andrea Russo; Matteo Fallico; Agnieszka Kaminska; Elina Ortisi; Stefano Zenoni; Michele Reibaldi Journal: J Ophthalmol Date: 2018-10-23 Impact factor: 1.909
Authors: Karen Brown; Nicolas A Yannuzzi; Natalia F Callaway; Nimesh A Patel; Nidhi Relhan; Thomas A Albini; Audina M Berrocal; Janet L Davis; Jorge A Fortun; William E Smiddy; Jayanth Sridhar; Harry W Flynn; Justin H Townsend Journal: Clin Ophthalmol Date: 2019-10-31